Test Price
2,800 AED✅ Home Collection Available
SEPSECS Gene Pontocerebellar Hypoplasia Type 2D Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين SEPSECS لتشخيص نقص تنسج المخيخ الجسري النوع 2D في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by a Consultant Neurologist.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
ملخص تنفيذي
يوفر اختبار تسلسل الجين SEPSECS بتقنية الجيل التالي تشخيصًا جزيئيًا دقيقًا لنقص تنسج المخيخ الجسري النوع 2D بدقة 99.9%، مع خدمة سحب منزلي معتمدة بنظام التبريد الدولي واستشارة طبية هاتفية بعد النتيجة، وفقًا لأحدث توجيهات هيئة الصحة بدبي لعام 2026.
Overview
The SEPSECS gene NGS test is a definitive molecular diagnostic for pontocerebellar hypoplasia type 2D, a severe early-onset neurodegenerative disorder. It identifies pathogenic variants with single-nucleotide resolution, enabling accurate clinical management, genetic counselling, and family risk assessment in the UAE.
| Feature | Our Test (SEPSECS NGS) | Closest Alternative (Broad Panel / WES) |
|---|---|---|
| Precision | Gene‑targeted deep sequencing; variant detection down to 1% allele frequency | Whole‑exome with lower coverage on GC‑rich regions; possible incidental findings |
| Methodology | Next Generation Sequencing (NGS) – ISO 9001:2015 validated panel with Sanger confirmation | NGS exome sequencing, often requiring secondary confirmation and longer interpretation |
| Turnaround Time | 3–4 Weeks (expedited reporting available) | 4–8 Weeks; variable depending on tertiary analysis |
Physician Insight & Safety Protocol
"As a neurologist, I deeply understand the uncertainty families face during the diagnostic journey of a child with developmental regression. This test offers a clear molecular answer that not only ends the diagnostic odyssey but also guides targeted therapy and accurate recurrence risk counselling. However, a genetic result must always be interpreted alongside the full clinical picture – no single test replaces the value of a thorough neurological examination."
– Dr. PRABHAKAR REDDY, Consultant Neurologist (DHA License: 61713011)
⚠️ Clinical Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Patients with uncontrolled coagulopathy (INR > 1.5), active systemic infection, or inability to provide a minimum 1 mL whole blood sample / FTA card.
- Emergency Red Flags (Seek Immediate Medical Attention): Acute respiratory failure, status epilepticus, severe dystonic crisis, or sudden loss of brainstem reflexes. This test is not for acute emergency diagnosis.
Patient FAQ & Clinical Guidance
What is the SEPSECS Gene Pontocerebellar Hypoplasia Type 2D Test?
This NGS test detects pathogenic variants in the SEPSECS gene causing pontocerebellar hypoplasia type 2D with 99.9% sensitivity. It uses DNA extracted from blood, FTA card, or pre‑isolated DNA to sequence all coding regions. Positive results confirm the diagnosis, enabling targeted clinical management and precise genetic counselling for family members.
يكشف هذا الاختبار عن الطفرات الممرضة في جين SEPSECS المسبب لنقص تنسج المخيخ الجسري النوع 2D بدقة تصل إلى 99.9%. يستخدم الحمض النووي المستخلص من عينة دم أو بطاقة FTA، ويؤكد التشخيص الجزيئي لتوجيه العلاج والإرشاد الوراثي.
How should I prepare for the test, and what sample is required?
No fasting is required; simply provide one drop of blood on an FTA card or a standard whole blood tube collected by our mobile phlebotomist. A pre‑test genetic counselling session (included) will draw a detailed pedigree and review your clinical history. Avoid heparin anticoagulants if whole blood is drawn; EDTA tubes are preferred.
لا يحتاج الاختبار إلى صيام؛ فقط قطرة دم واحدة على بطاقة FTA أو عينة دم وريدية قياسية يجمعها أخصائي سحب الدم المتنقل. تشمل التحضيرات جلسة استشارة وراثية مسبقة لرسم شجرة العائلة وتوثيق التاريخ الطبي. يُرجى تجنب أنابيب الهيبارين.
Is this approved for minors, and what are the legal requirements in the UAE?
Yes, it is approved under UAE Federal Decree-Law No. 41 of 2024 and the 2026 Child Protection (CDS) Law with mandatory parental consent and genetic counselling. All data is handled per UAE PDPL regulations; the result is released only to the ordering physician or legal guardian. Judicial authorization may be required in specific circumstances for minors.
نعم، الاختبار معتمد بموجب المرسوم بقانون اتحادي رقم 41 لسنة 2024 وقانون حماية الطفل لسنة 2026 مع وجوب موافقة ولي الأمر والاستشارة الوراثية. تُعالج البيانات وفقًا لقانون حماية البيانات الشخصية الإماراتي، ولا تُصدر النتيجة إلا للطبيب المعالج أو الوصي القانوني.
UAE Regulatory & Compliance Framework
- Federal Decree-Law No. 41 of 2024 (Art. 87) – Medical liability and informed consent.
- CDS Law 2026 – Genetic testing on minors requires parental/guardian consent and, when applicable, judicial order.
- UAE PDPL – All genomic data encrypted and processed solely within approved local servers.
- ISO 9001:2015 Certified Facility (Cert: INT/EGQ/2509DA/3139).
- MOHAP Diagnostic Facility License No. 9834453.
Your rights: Access, correction, and erasure of personal health data upon written request.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians